Bank of The Ozarks raised its position in MetLife, Inc. (NYSE:MET) by 0.1% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,573 shares of the financial services provider’s stock after buying an additional 12 shares during the period. Bank of The Ozarks’ holdings in MetLife were worth $1,076,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the company. Schwab Charles Investment Management Inc. boosted its position in shares of MetLife by 5.2% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,555,656 shares of the financial services provider’s stock worth $195,348,000 after buying an additional 175,311 shares during the last quarter. Forward Management LLC boosted its position in shares of MetLife by 0.4% in the second quarter. Forward Management LLC now owns 9,661 shares of the financial services provider’s stock worth $531,000 after buying an additional 41 shares during the last quarter. Wetherby Asset Management Inc. boosted its position in shares of MetLife by 1.8% in the second quarter. Wetherby Asset Management Inc. now owns 14,163 shares of the financial services provider’s stock worth $778,000 after buying an additional 247 shares during the last quarter. General American Investors Co. Inc. boosted its position in shares of MetLife by 5.3% in the second quarter. General American Investors Co. Inc. now owns 400,000 shares of the financial services provider’s stock worth $21,976,000 after buying an additional 20,000 shares during the last quarter. Finally, Global X Management Co. LLC boosted its position in shares of MetLife by 12.1% in the second quarter. Global X Management Co. LLC now owns 8,404 shares of the financial services provider’s stock worth $462,000 after buying an additional 910 shares during the last quarter. Institutional investors own 74.23% of the company’s stock.

MetLife, Inc. (NYSE MET) opened at 47.57 on Tuesday. The firm’s 50-day moving average is $48.46 and its 200-day moving average is $47.25. MetLife, Inc. has a 12 month low of $37.17 and a 12 month high of $52.07. The firm has a market capitalization of $50.56 billion, a PE ratio of 559.65 and a beta of 1.46.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The business’s quarterly revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.83 EPS. On average, equities research analysts expect that MetLife, Inc. will post $4.83 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 3.36%. The ex-dividend date is Thursday, August 3rd. MetLife’s dividend payout ratio (DPR) is 1,777.98%.

ILLEGAL ACTIVITY NOTICE: “Bank of The Ozarks Boosts Stake in MetLife, Inc. (MET)” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/29/bank-of-the-ozarks-boosts-stake-in-metlife-inc-met.html.

A number of brokerages have issued reports on MET. Credit Suisse Group restated a “neutral” rating and set a $53.00 target price (down previously from $64.00) on shares of MetLife in a research report on Monday. ValuEngine downgraded shares of MetLife from a “strong-buy” rating to a “buy” rating in a report on Saturday. TheStreet downgraded shares of MetLife from a “b-” rating to a “c+” rating in a report on Monday, August 21st. Langen Mcalenn reiterated a “buy” rating on shares of MetLife in a report on Wednesday, August 16th. Finally, Barclays PLC lowered their price target on shares of MetLife from $67.00 to $60.00 and set an “overweight” rating for the company in a report on Friday, August 11th. Two analysts have rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $59.31.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.